VCYT - VERACYTE, INC.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 20.35

Open

$ 21.10

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 20.29 - $ 21.10

52 Week Range

$ 18.61 - $ 30.52

Volume

463,840

Average Volume

Market Cap

1.48B

Beta (5Y Monthly)

$ 1.76

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-29-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-09-2023	06-30-2023	10-Q
4	05-05-2023	03-31-2023	10-Q
5	03-01-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-03-2022	06-30-2022	10-Q
8	05-03-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	07-29-2021	06-30-2021	10-Q
12	05-10-2021	03-31-2021	10-Q
13	02-22-2021	12-31-2020	10-K
14	11-02-2020	09-30-2020	10-Q
15	07-30-2020	06-30-2020	10-Q
16	05-06-2020	03-31-2020	10-Q
17	02-25-2020	12-31-2019	10-K
18	10-22-2019	09-30-2019	10-Q
19	07-30-2019	06-30-2019	10-Q
20	04-30-2019	03-31-2019	10-Q
21	02-25-2019	12-31-2018	10-K
22	10-29-2018	09-30-2018	10-Q
23	07-23-2018	06-30-2018	10-Q
24	05-01-2018	03-31-2018	10-Q
25	02-27-2018	12-31-2017	10-K
26	11-07-2017	09-30-2017	10-Q
27	07-31-2017	06-30-2017	10-Q
28	05-03-2017	03-31-2017	10-Q
29	03-01-2017	12-31-2016	10-K
30	11-03-2016	09-30-2016	10-Q
31	08-03-2016	06-30-2016	10-Q
32	05-05-2016	03-31-2016	10-Q
33	03-14-2016	12-31-2015	10-K
34	11-05-2015	09-30-2015	10-Q
35	08-13-2015	06-30-2015	10-Q
36	05-15-2015	03-31-2015	10-Q
37	03-25-2015	12-31-2014	10-K
38	11-13-2014	09-30-2014	10-Q
39	08-14-2014	06-30-2014	10-Q
40	05-09-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Veracyte's New Study Shows The Decipher Pr...
04/22/2024 12:42:54

Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision...

Veracyte Announces 9 Abstracts Reinforcing...
04/16/2024 12:42:48

Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that nine abstracts focused on its Decipher...

Goldman Sachs Maintains Buy on Veracyte, L...
04/15/2024 14:33:35

Goldman Sachs analyst Matthew Sykes maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $32 to $28.

cathie-woods-ark-invest-dumps-17m-in-coinbase-shares-as-the-exchange-grappled-with-disruption-amid-bitcoin-rally

Cathie Wood's Ark Invest Dumps $17M In Coi...
02/29/2024 04:02:13

On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASD...

cathie-woods-ark-invest-sheds-93m-worth-of-coinbase-shares-amid-bitcoin-rally--robinhood-stock-also-sold

Cathie Wood's Ark Invest Sheds $9.3M Worth...
02/28/2024 03:35:54

On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades.

cathie-woods-ark-invest-offloads-69m-worth-of-coinbase-robinhood-shares-each-amid-searing-bitcoin-rally--nvidia-stock-also-shed

Cathie Wood's Ark Invest Offloads $6.9M Wo...
02/27/2024 03:45:00

On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such a...

Morgan Stanley Maintains Underweight on Ve...
02/26/2024 16:16:42

Morgan Stanley analyst Tejas Savant maintains Veracyte (NASDAQ:VCYT) with a Underweight and lowers the price target from $22...

Needham Maintains Buy on Veracyte, Raises ...
02/23/2024 10:34:34

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $30 to $33.

Veracyte Sees FY24 Revenue $394M-$402M Vs ...
02/22/2024 22:17:55

Recap: Veracyte Q4 Earnings
02/22/2024 21:55:23

Veracyte Q4 2023 Adj EPS $0.05 Beats $(0.0...
02/22/2024 21:54:41

Veracyte (NASDAQ:VCYT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.09) by 1...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Earnings Outlook For Veracyte
02/21/2024 17:01:04

cathie-woods-ark-invest-buys-over-92m-worth-of-proshares-bitcoin-etf-sells-coinbase-block-and-palantir-shares

Cathie Wood's Ark Invest Buys Over $92M Wo...
12/28/2023 04:19:54

On Wednesday, Cathie Wood-led Ark Invest made a significant move in the cryptocurrency space, purchasing over $92 million worth...

Clinical Validation Data Published In CHES...
11/29/2023 13:35:45

Non-invasive genomic test is designed to help physicians guide next steps for current and former smokers with lung nodulesVerac...

Veracyte Announces Seven Posters Highlight...
11/22/2023 13:32:46

Morgan Stanley Maintains Underweight on Ve...
11/10/2023 14:26:43

Morgan Stanley analyst Tejas Savant maintains Veracyte (NASDAQ:VCYT) with a Underweight and lowers the price target from $23...

Needham Maintains Buy on Veracyte, Lowers ...
11/08/2023 22:02:43

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $35 to $30.

Veracyte Raises FY23 Revenue From $342M-$3...
11/08/2023 01:31:36

2023 Financial OutlookThe company is raising full-year 2023 total revenue guidance to $352 million to $354 million, representin...

Veracyte: Q3 Earnings Insights
11/07/2023 21:35:28